...hired Chris Chapman as CCO. He was VP and general manager, U.S. prescription business at Galderma Laboratories L.P. BioCentury...

...Former Shire CEO Flemming Ørnskov will lead newly independent Galderma Laboratories L.P. as CEO. Joining him is fellow...

...development, regulatory and commercial milestones, plus royalties. FDA approval for Aklief acne cream FDA approved Galderma Laboratories L.P.’s...
...epicutaneously. Jonathan Block, Associate Editor Viaskin Peanut (DBV-712) Editas Medicine Inc. MaxCyte Inc. Takeda Pharmaceutical Co. Ltd. Goldfinch Biopharma Inc. DBV Technologies S.A. Galderma...

...humanized mAb against IL-31 receptor α for skin diseases from Chugai Pharmaceutical Co. Ltd. (Tokyo:4519). Galderma...
...atopic dermatitis by mid-year (see "Galderma Planning Phase III Program for Atopic Dermatitis Therapy" ). Galderma...

...start a Phase III program of the humanized mAb against IL-31 receptor α by mid-year. Galderma...
...concomitant topical corticosteroids. Data were presented at the American Academy of Dermatology meeting in Washington. Galderma...

...succeeds former CMO James Lee. Brown was head of global pharmaceutical drug development at the Galderma...

...could include using the implants to deliver other immunotherapy agents in models of solid tumors. Galderma...

...A complex supplied as a lyophilized powder, is approved in more than 80 countries. The Galderma...
...Euronext:IPN; Pink:IPSEY), Boulogne-Billancourt, France Product: Dysport abobotulinumtoxinA ( Azzalure - EU) (formerly Reloxin) Business: Musculoskeletal Julian Zhu abobotulinumtoxinA Azzalure Dysport Galderma...

...financial terms. Galderma S.A. , Lausanne, Switzerland Bioventus Inc. , Durham, N.C. Business: Neurology Shannon Lehnbeuter Durolane Bioventus Inc. Galderma...

...type A complex supplied as a lyophilized powder is approved in over 80 countries. The Galderma...